From: FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer
Parameter | n | FOXA1 | p | AR | p | ||
---|---|---|---|---|---|---|---|
 |  | High | Low |  | High | Low |  |
Age | Â | Â | Â | Â | Â | Â | Â |
≤55 | 31 | 21 | 10 | 0.916 | 19 | 12 | 0.493 |
>55 | 45 | 31 | 14 | Â | 31 | 14 | Â |
FIGO stage | Â | Â | Â | Â | Â | Â | Â |
I–II | 64 | 41 | 23 | 0.059 | 41 | 23 | 0.464 |
III–IV | 12 | 11 | 2 |  | 9 | 3 |  |
Pathological type | Â | Â | Â | Â | Â | Â | Â |
Adenocarcinoma | 63 | 47 | 16 | 0.469 | 41 | 22 | 0.774 |
Papillary serous carcinoma | 13 | 10 | 3 | Â | 9 | 4 | Â |
Histological grade | Â | Â | Â | Â | Â | Â | Â |
G1 | 35 | 19 | 16 | 0.038 | 18 | 17 | 0.040 |
G2 | 22 | 17 | 5 | Â | 18 | 4 | Â |
G3 | 6 | 6 | 0 | Â | 5 | 1 | Â |
Lymph node metastasis | Â | Â | Â | Â | Â | Â | Â |
Positive | 7 | 6 | 1 | 0.271 | 5 | 2 | 0.86 |
Negative | 66 | 43 | 23 | Â | 45 | 21 | Â |
Depth of myometrial invasion | Â | Â | Â | Â | Â | Â | Â |
≤1/2 | 47 | 28 | 19 | 0.035 | 29 | 18 | 0.339 |
>1/2 | 29 | 24 | 5 | Â | 21 | 8 | Â |
ERα expression |  |  |  |  |  |  |  |
Positive | 61 | 43 | 18 | 0.434 | 41 | 20 | 0.598 |
Negative | 15 | 9 | 6 | Â | 9 | 6 | Â |
P53 expression | Â | Â | Â | Â | Â | Â | Â |
Positive | 20 | 14 | 6 | 0.86 | 15 | 5 | 0.312 |
Negative | 56 | 38 | 18 | Â | 35 | 21 | Â |